EXPLORE THE SCIENCE
TL;DR: In 3 large birth studies covering 5.3 million children, kids whose mothers had type 1 or type 2 diabetes before pregnancy were about a third more likely to develop epilepsy. Diabetes that first appears during pregnancy showed no clear link, and none of…
Read article
TL;DR: A 2026 narrative review in Journal of Central Nervous System Disease found that glucagon-like peptide-1 receptor agonists have promising stroke-prevention and animal-model evidence, but human data do not yet support routine use as an acute ischemic stro…
Read article
TL;DR: A 2026 real-world cohort study in Journal of Diabetes & Metabolic Disorders linked GLP-1 receptor agonists, drugs targeting a glucose-related metabolic hormone pathway, to a higher hazard of new hypersomnolence, but the absolute risk increase was small.…
Read article
TL;DR: A 2026 uncontrolled pilot study in BJPsych Open found that SMART, a personalized text-message program for metabolic health in people with schizophrenia spectrum disorders, improved patient activation, diabetes self-management confidence, health literacy…
Read article
TL;DR: A 2026 systematic review and meta-analysis in Neuropsychopharmacology found that dopamine D2-like receptor activation suppressed glucose-stimulated insulin secretion (GSIS), insulin release after high glucose, in animal pancreatic cells, suggesting one…
Read article
Metformin’s Secret Weapon: How the Brain Controls Blood Sugar TL;DR: Metformin’s glucose-lowering effect depends on a brain signaling pathway—it inhibits Rap1 in the hypothalamus, activating neurons that tell the liver to stop overproducing glucose. For decade…
Read article
Diabetes and Depression Are Not Just Comorbidities—They Drive Each Other TL;DR: Diabetes and depression form a vicious cycle: high blood sugar triggers neuroinflammation and HPA axis dysfunction that cause depression, while depression sabotages blood sugar con…
Read article
This study shows that type 2 diabetes causes decreased blood flow and changes in neural activity in specific parts of the hippocampus, which may initially compensate for cognitive decline but deteriorate with worsening diabetes. Highlights: Decreased Perfusion…
Read article
GLP-1 receptor agonists like semaglutide, used for managing Type 2 diabetes, may be linked to adverse mood changes, necessitating further investigation into their psychiatric effects. Highlights: GLP-1 Receptor Agonists: These medications mimic GLP-1 hormone e…
Read article
TLDR: GLP-1 agonists were found to significantly reduce the risk of dementia in older individuals with type 2 diabetes mellitus (T2DM) compared to DPP-4 inhibitors and sulfonylureas. Highlights: A sequential trial emulation was conducted using data from Swedis…
Read article